Chemoinformaics analysis of (+)-16-Gammaceren-3beta-ol
| Molecular Weight | 426.729 | nRot | 0 |
| Heavy Atom Molecular Weight | 376.329 | nRig | 26 |
| Exact Molecular Weight | 426.386 | nRing | 5 |
| Solubility: LogS | -6.43 | nHRing | 0 |
| Solubility: LogP | 6.758 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 84.2417 |
| nHD | 1 | BPOL | 50.1604 |
| QED | 0.387 |
| Synth | 4.706 |
| Natural Product Likeliness | 2.794 |
| NR-PPAR-gamma | 0.233 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -5.102 |
| MDCK | 0.00000754 |
| BBB | 0.254 |
| PPB | 0.971856 |
| VDSS | 1.303 |
| FU | 0.0207868 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.599 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.959 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.749 |
| CYP2d6-inh | 0.081 |
| CYP2d6-sub | 0.858 |
| CYP3a4-inh | 0.302 |
| CYP3a4-sub | 0.271 |
| CL | 4.628 |
| T12 | 0.086 |
| hERG | 0.012 |
| Ames | 0.002 |
| ROA | 0.14 |
| SkinSen | 0.894 |
| Carcinogencity | 0.011 |
| EI | 0.921 |
| Respiratory | 0.93 |
| NR-Aromatase | 0.403 |
| Antiviral | No |
| Prediction | 0.775049 |